Prime Medicine, Inc.PRMENASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+20.6%
5Y CAGR+75.3%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+20.6%/yr
Annual compound
5Y CAGR
+75.3%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
16.6x
Strong expansion
Streak
6 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$52.35M+4.4%
2024$50.16M+15.6%
2023$43.39M+45.5%
2022$29.82M+114.2%
2021$13.92M+340.4%
2020$3.16M+152.6%
2019$1.25M-